Craft

Prime Medicine

Stock Price

$4.1

2024-10-29

Market Capitalization

$489.7 M

2024-10-29

Revenue

$4.6 M

FY, 2025

Prime Medicine Summary

Company Summary

Overview
Prime Medicine is a biotechnology company that develops a gene-editing technology. It uses Prime Editing technology that acts as a DNA word processor to search and replace disease-causing genetic sequences at their precise location in the genome.
Type
Public
Status
Active
Founded
2019
HQ
Cambridge, MA, US | view all locations
Website
https://www.primemedicine.com
Cybersecurity rating
Sectors

Key People

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    21 Erie St

Prime Medicine Financials

Summary Financials

Net income (Q1, 2026)
($49.1M)
Cash (Q1, 2026)
$64.1M
EBIT (Q1, 2026)
($50.7M)
Enterprise value
$540.1M

Footer menu